Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Controversies in ammonia metabolism: implications for hepatic encephalopathy.

Literature DB >> 17828448

Controversies in ammonia metabolism: implications for hepatic encephalopathy.

Alan H Lockwood¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Ammonia

Year: 2007 PMID： 17828448 DOI： 10.1007/s11011-007-9059-0

Source DB: PubMed Journal: Metab Brain Dis ISSN： 0885-7490 Impact factor: 3.584

× No keyword cloud information.

21 in total

1. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis.

Authors: Björn Ahl; Karin Weissenborn; Jörg van den Hoff; Daniela Fischer-Wasels; Herbert Köstler; Hartmut Hecker; Wolfgang Burchert
Journal: Hepatology Date: 2004-07 Impact factor: 17.425

Review 2. Branched-chain amino acids in the management of hepatic encephalopathy: an analysis of variants.

Authors: L S Eriksson; H O Conn
Journal: Hepatology Date: 1989-08 Impact factor: 17.425

3. Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine?

Authors: L Zieve; R L Olsen
Journal: Gut Date: 1977-09 Impact factor: 23.059

4. Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial.

Authors: F B Cerra; N K Cheung; J E Fischer; N Kaplowitz; E R Schiff; J L Dienstag; R H Bower; C D Mabry; C M Leevy; T Kiernan
Journal: JPEN J Parenter Enteral Nutr Date: 1985 May-Jun Impact factor: 4.016

5. Factors that affect the uptake of ammonia by the brain: the blood-brain pH gradient.

Authors: A H Lockwood; R D Finn; J A Campbell; T B Richman
Journal: Brain Res Date: 1980-01-13 Impact factor: 3.252

6. The metabolic fate of 13N-labeled ammonia in rat brain.

Authors: A J Cooper; J M McDonald; A S Gelbard; R F Gledhill; T E Duffy
Journal: J Biol Chem Date: 1979-06-25 Impact factor: 5.157

7. Standard and higher doses of bromocriptine for severe chronic portal-systemic encephalopathy.

Authors: M Uribe; G García-Ramos; M Ramos; C Valverde; M A Márquez; A Farca; L Guevara
Journal: Am J Gastroenterol Date: 1983-08 Impact factor: 10.864

8. The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia.

Authors: A H Lockwood; J M McDonald; R E Reiman; A S Gelbard; J S Laughlin; T E Duffy; F Plum
Journal: J Clin Invest Date: 1979-03 Impact factor: 14.808

9. Is intravenous administration of branched chain amino acids effective in the treatment of hepatic encephalopathy? A multicenter study.

Authors: J Wahren; J Denis; P Desurmont; L S Eriksson; J M Escoffier; A P Gauthier; L Hagenfeldt; H Michel; P Opolon; J C Paris; M Veyrac
Journal: Hepatology Date: 1983 Jul-Aug Impact factor: 17.425

10. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.

Authors: H Michel; M Solere; P Granier; G Cauvet; J P Bali; F Pons; H Bellet-Hermann
Journal: Gastroenterology Date: 1980-08 Impact factor: 22.682

4 in total

1. Blood-brain barrier permeability for ammonia in patients with different grades of liver fibrosis is not different from healthy controls.

Authors: Annemarie Goldbecker; Ralph Buchert; Georg Berding; Martin Bokemeyer; Ralf Lichtinghagen; Florian Wilke; Björn Ahl; Karin Weissenborn
Journal: J Cereb Blood Flow Metab Date: 2010-03-10 Impact factor: 6.200